Updated on 18 August 2026
World-leading Elastic Textile-PCB
CEO at Easenory Technology Limited
China (Hong Kong)
About
Easenory Technology Limited offers next-generation elastic electronic solutions for robotics, wearables and intelligent sensing applications.
Our technology helps make electronic systems softer, more comfortable and more durable. It enables stretchable, breathable, washable and conformable electronic structures that can integrate naturally with the human body or robotic surfaces.
We provide solutions including soft multimodal sensing bands, elastic interconnects and sensing systems for humanoid robotics, dexterous hands, consumer electronics and health-related applications. We are seeking partners for product development, pilot projects, manufacturing, investment and commercialisation across the Belt and Road region.
Project Location
- China
Project Format
- Private Project
Go Global Project
- Yes
ESG (Environmental, Social, and Governance)
- No
Project Stage
- Partner Identification
Main Project Sector
- Technology
Manufacturing
Advanced manufacturing
Technology
- Intelligent Manufacturing
- IoT
Total Project Value
- 10,000,001 to 25,000,000 USD
Investment Capital Required
- 1,000,001 to 2,500,000 USD
Interested Format of Cooperation
- Direct Equity Investment
Preferred Financing Model
- Equity
Type(s) of Last Financing Round of the project (if Applicable)
- Venture Capital (VC)
Main Service(s) Required
- Professional Services
Attached files
Similar opportunities
Service
Elastic Electronics for Robotics and Wearables
- IoT
- Industry Solutions
Ceci Wu
Director at Easenory Technology Limited
China (Hong Kong)
Project
CODI - Robot-Assisted Echocardiography
- Yes
- Yes
- Equity
- Technology
- Private Project
- Health Technology
- Medical Technology
- Financial Services
- Investment Banking
- Venture Capital (VC)
- Minority Shareholdings
- Direct Equity Investment
- 10,000,001 to 25,000,000 USD
- 10,000,001 to 25,000,000 USD
- Private Equity & Venture Capital
- Investment / Financing Discussion
Matthew Sefati
CEO at Cobionix
Canada
Project
AI enabled Acceleration of Preclinical Biologic Drug Development
- No
- Yes
- Equity
- Bio-Tech
- Technology
- Private Project
- Equity (private)
- Financial Services
- Partner Identification
- Direct Equity Investment
- 10,000,001 to 25,000,000 USD
- Private Equity & Venture Capital
Kingsley Leung
Chairman & Co-founder at Great Bay Bio Limited
China (Hong Kong)